Replies to post #21625 on Humanigen Inc (fka HGENQ)

[rstar]

looks like the Bryan Garnier analyst BUY recco and 30 price target written by Olga Smolentsetva, who I have heard asking questions on a bunch of calls

HUMANIGEN: OWS support and enrolment expansion bode well for phase III readout, now in 1Q21 | BUY | USD30

HUMANIGEN - BUY | USD30
OWS support and enrolment expansion bode well for phase III readout, now in 1Q21

Lenzilumab gets the endorsement from OWS
With hitting ‘promising zone’, Humanigen is expanding target enrolment of the phase III
Timing for the expected phase III readout is pushed into Q1 2021
09/11/2020
4
EN